ROCK1抑制劑Y-27632
| 【Numbering】BKMC130001 | 【CAS】CAS | ||
| 【Item No.】BKMC130001-2 | 【specification】 | ||
|
|||
Name: Y-27632
Composition: C14H21N3O
Particle size: small molecules
Application: Anti-angiogenesis
Storage conditions: -20℃
Other instructions: sealed state shelf life for half a year [main advantage] ROCK 1 inhibitor Y-27632 alone can be high expression of TEM 8 triple negative breast cancer growth and vascular mimetic formation has very good inhibition, and combined with chemotherapy drug docetaxel not only has more obvious tumor growth and vascular mimetic formation inhibition effect, but also can significantly inhibit tumor stem cell enrichment caused by docetaxel therapy.
Title:TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer
Message
Composition: C14H21N3O
Particle size: small molecules
Application: Anti-angiogenesis
Storage conditions: -20℃
Other instructions: sealed state shelf life for half a year [main advantage] ROCK 1 inhibitor Y-27632 alone can be high expression of TEM 8 triple negative breast cancer growth and vascular mimetic formation has very good inhibition, and combined with chemotherapy drug docetaxel not only has more obvious tumor growth and vascular mimetic formation inhibition effect, but also can significantly inhibit tumor stem cell enrichment caused by docetaxel therapy.
Title:TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer
Article link:https://zhuanlan.zhihu.com/p/394349782
| Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance |
Message
|
| Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance.The website pictures are from the Internet. The pictures are for reference only. Please take the real object as the standard. In case of infringement, please contact us to delete them immediately. |
Previous： the end...
Next： 仿生巨噬細(xì)胞膜載CRISPR/Cas9
